Top Health Care Stocks
Health care stocks were finishing higher Thursday afternoon, with the NYSE Health Care Index gaining 0.4% while shares of health care companies in the S&P 500 were up 0.6% as a group.
In company news, Aethlon Medical ( AEMD ) rallied to a two-year on Thursday after researchers at the medical device company completed in-vitro studies demonstrating the “rapid capture” of the Zika virus by the company’s Hemopurifier.
The Hemopurifier selectively targets the elimination of circulating viruses and sheds glycoproteins to treat infectious viral pathogens. The Zika studies used small-scale versions of the device, removing about 95% of the Zika viruses from cell culture fluid over a 5.5-hour span and around half of the viruses from human blood serum in 5 hours.
Separately, Aethlon today also said the Defense Advanced Research Projects Agency has revised an existing contract with the company to now validate the in-vitro capture of the Middle East respiratory syndrome coronavirus as part of the federal agency’s Dialysis-Like Therapeutics program.
AEMD shares were up almost 24% at $7.71 in late trade, easing from a mid-morning jump to their best price since August 2014 at $9.09 a share.
In other sector news,
(+) KURA, Expand Phase II trial after reporting partial responses by two patients with a form of head and neck cancer following treatment with its tipifarnib drug candidate. Disease stabilized for a third cancer patient.
(-) AVGR, Prices $30 mln offering of 8.57 mln shares at $3.50 each, a 24.2% discount to Wednesday’s closing price. Net proceeds will help repay $40.1 mln loan from CRG Partners III and resolving potential compliance issue with loan covenant requiring at least $23 mln in revenue for AVGR this year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.